The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas.
about
Laser photocoagulation for radiation retinopathy after ophthalmic plaque radiation therapyReview of advanced catheter technologies in radiation oncology brachytherapy proceduresClinical implementation of a new electronic brachytherapy system for skin brachytherapyPolyethylene Naphthalate Scintillator: A Novel Detector for the Dosimetry of Radioactive Ophthalmic ApplicatorsGuidelines by the AAPM and GEC-ESTRO on the use of innovative brachytherapy devices and applications: Report of Task Group 167.The potential of proton beam radiation therapy in intracranial and ocular tumours.Comparison of dose calculation methods for brachytherapy of intraocular tumors.Novel low-kVp beamlet system for choroidal melanomaEpiscleral plaque brachytherapy using 'BARC I-125 Ocu-Prosta seeds' in the treatment of intraocular tumors: a single-institution experience in IndiaRuthenium-106 brachytherapy for thick uveal melanoma: reappraisal of apex and base dose radiation and dose rateLong-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy.Dosimetry and treatment planning of Occu-Prosta I-125 seeds for intraocular lesions.Uveal melanoma treated with iodine-125 episcleral plaque: an analysis of dose on disease control and visual outcomes.Brachytherapy of intra ocular tumors using 'BARC I-125 Ocu-Prosta seeds': an Indian experience.Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.Model-based dose calculations for COMS eye plaque brachytherapy using an anatomically realistic eye phantom.Enhancements to commissioning techniques and quality assurance of brachytherapy treatment planning systems that use model-based dose calculation algorithms.Outcomes and control rates for I-125 plaque brachytherapy for uveal melanoma: a community-based institutional experience.The retina dose-area histogram: a metric for quantitatively comparing rival eye plaque treatment options.Monte Carlo Simulation of the Treatment of Eye Tumors with (106)Ru Plaques: A Study on Maximum Tumor Height and Eccentric PlacementVisual acuity, oncologic, and toxicity outcomes with 103Pd vs. 125I plaque treatment for choroidal melanoma.Keeping an eye on the ring: COMS plaque loading optimization for improved dose conformity and homogeneity.(103)Pd versus (125)I ophthalmic plaque brachytherapy: preoperative comparative radiation dosimetry for 319 uveal melanomasIndependent dosimetric assessment of the model EP917 episcleral brachytherapy plaque.Eccentric ruthenium plaque radiotherapy of posterior choroidal melanoma.A prospective analysis of ¹⁸F-FDG PET/CT in patients with uveal melanoma: comparison between metabolic rate of glucose (MRglu) and standardized uptake value (SUV) and correlations with histopathological features.Point/Counterpoint. Particle therapy is ideal for the treatment of ocular melanomas.Episcleral brachytherapy for uveal melanoma: analysis of 136 cases.An approach to using conventional brachytherapy software for clinical treatment planning of complex, Monte Carlo-based brachytherapy dose distributions.BEDVH-A method for evaluating biologically effective dose volume histograms: application to eye plaque brachytherapy implants.Improving quality assurance for assembled COMS eye plaques using a pinhole gamma camera.Radiobiology for eye plaque brachytherapy and evaluation of implant duration and radionuclide choice using an objective function.Delivered dose uncertainty analysis at the tumor apex for ocular brachytherapy.Novel application of 3D printing in brachytherapy using MED610 3D printed insert for I-125 ROPES eye plaque.Evaluation of material heterogeneity dosimetric effects using radiochromic film for COMS eye plaques loaded with (125)I seeds (model I25.S16).Ocular brachytherapy dosimetry for 103Pd and 125I in the presence of gold nanoparticles: a Monte Carlo study.COMS eye plaque brachytherapy dosimetry simulations for P103d, I125, and C131s.Dose verification of eye plaque brachytherapy using spectroscopic dosimetry.Method for verifying the air kerma strength of I-125 plaques for the treatment of ocular melanoma.Gamma irradiation of ocular melanoma and lymphoma cells in the presence of gold nanoparticles: in vitro study.
P2860
Q24670470-64819937-74CC-4FD7-BE71-2472E55E25FFQ26800257-A56EB7EB-9F53-49FF-953C-FD783BE0E9DCQ26865336-B7A8A77E-2B31-43C2-A1EF-F865BC73512FQ28834090-B12AD99F-0951-40E5-B688-81E6A6FC4D5DQ30151984-6CC14AF4-7D99-4825-98F0-DE6DB4F938B9Q33272454-FA2C3245-4145-4496-B14D-056FEB122F76Q34493736-3F5B1EA2-390D-43B4-94C9-6D45405DAA61Q35062370-4A5E8617-2B0C-4F8C-944C-C924D4B0165DQ36234605-0AE1F735-4322-4934-9999-942A842885EEQ36690535-BEC7B8AB-7278-4889-8316-DC67AABAAFE8Q37188699-9B126BB9-B3F9-496F-B12F-83EEEBEBE1EEQ37449854-FAB071A9-F1C9-4CE5-AB99-E80B2681D493Q37705141-52844F38-DC11-4715-878B-63E6FC4857E9Q37733430-BE3A7D9A-7BA3-4F54-95FF-2FA4E4AFC6BCQ38049632-1586ECC6-F03F-493E-B92E-70F616CE17C3Q38186120-30D46437-0DEF-462C-A8DB-2A94D9556530Q38428469-5480978E-13A7-4CA5-871C-448A157009CAQ38480299-D2811AAF-CE42-4D06-ADD7-D0D8F5C3147EQ40068067-7859503C-D902-4274-872D-F3C85A7DB5F3Q41444688-251FD1C8-52E2-4826-8C90-D7F636EB1DCAQ41625689-43BD32D0-AD18-479B-88E4-8907FE0D17D2Q41824320-BA0CE37A-275F-40F2-9A51-82B2C413A854Q42037875-DB4A0981-0853-4E22-BB3F-3B0D708760A5Q42465010-D0966D15-C5DD-4696-97D0-DCA161376917Q42502445-F2034FF2-6365-4F0E-8F6C-79F6C89D38C6Q43773426-65A206C1-09EE-4B40-A303-D5B6AD9FDA06Q44112923-1D99B561-D170-446B-9754-EB8EC801C2F4Q44357895-2AAE8AE9-20C7-43B4-8B5A-72F950A8C4F2Q44362054-BA088054-2B42-4F9D-888B-406284AE206CQ46673817-C6459008-B02B-4D71-8A27-D90918C504E3Q47261864-0480E803-34E6-42FF-8CEF-6BFEEEC62032Q47424554-78578386-A946-4887-B84A-6FEE725894A0Q47724293-E6227F2E-5E49-4274-8577-684B2E076AA6Q48307127-17C4D5AE-D3FF-47FA-A576-63A8ECEFE88BQ49021743-1F9FDCEB-1619-49C2-9720-4CDE6EEFA6D6Q51336675-5F099C1E-92E2-498F-9CAB-09E12CB447D2Q51874224-6EF6D2E1-9B98-493E-86AC-66C8A1BB7FE2Q53059023-3F1118A8-EF8F-4554-94AF-CECC0E6FC8C5Q55030160-0D79F71C-330A-42F2-BBFD-733496622EB2Q55034746-4530670B-BFAB-4771-8CD0-E8B32DA5D932
P2860
The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas.
@ast
The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas.
@en
type
label
The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas.
@ast
The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas.
@en
prefLabel
The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas.
@ast
The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas.
@en
P2093
P1476
The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas
@en
P2093
American Brachytherapy Society
David Followill
James Fontanesi
Jeanne M Quivey
John D Earle
P304
P356
10.1016/S0360-3016(03)00006-3
P407
P577
2003-06-01T00:00:00Z